Wei-Peng Wang
Overview
Explore the profile of Wei-Peng Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
728
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma X, Yu X, Wang W, Meng Y, Xu X
Ying Yong Sheng Tai Xue Bao
. 2024 Dec;
35(10):2755-2764.
PMID: 39727122
We elucidated the changes of soil microbial biomass and community structure in soil profiles under four typical land use types (farmland, grassland, secondary forest and plantation)and across five soil layers...
2.
Ouyang Z, Shao L, Wang W, Ke T, Chen D, Zheng G, et al.
Redox Rep
. 2023 Aug;
28(1):2251237.
PMID: 37652897
Objective: It is very important to develop a new therapeutic strategy to cope with the increasing morbidity and mortality of chronic kidney disease (CKD). As a kind of physical therapy,...
3.
Song J, Jiang Y, Gao T, Yao Y, Liu L, Xu R, et al.
Chin Med J (Engl)
. 2020 Jun;
133(13):1617-1619.
PMID: 32501830
No abstract available.
4.
Wang J, Wang W
Cell Immunol
. 2019 Nov;
347:104008.
PMID: 31733822
The coinhibitory molecule B7-H4, an important member of the B7 family, is abnormally expressed in tumors, inflammation and autoimmune diseases. B7-H4 negatively regulates T cell immune response and promotes immune...
5.
Qu L, Geng Z, Wang W, Yang K, Wang W, Han C, et al.
J Hazard Mater
. 2019 Jul;
379:120823.
PMID: 31276918
A three-dimensional (3D) substrate was developed by assembling a monolayer of graphitic carbon nitride (O-g-CN) on Ag nanorod arrays (Ag NRs) for sensitive and recyclable surface enhanced Raman scattering (SERS)...
6.
Tao L, Zhou X, Li F, Chen Q, Meng F, Mao Y, et al.
Cancer Immunol Immunother
. 2016 Nov;
66(3):309-318.
PMID: 27889799
PD-L1 is a member of the B7 family co-inhibitory molecules and plays a critical role in tumor immune escape. In this study, we found a polymorphism rs10815225 in the PD-L1...
7.
Zhao Y, Tu M, Wang W, Qiu J, Yu A, Yu A
Sci Rep
. 2016 May;
6:26611.
PMID: 27216562
Osteosarcoma (OS) is the most common primary malignant bone tumor in children, and microRNA-34a (miR-34a) replacement therapy represents a new treatment strategy. This study was to define the effectiveness and...
8.
Zhao Y, Tu M, Yu Y, Wang W, Chen Q, Qiu J, et al.
Biochem Pharmacol
. 2015 Nov;
98(4):602-13.
PMID: 26518752
Osteosarcoma (OS) is the most common form of primary malignant bone tumor and prevalent among children and young adults. Recently we have established a novel approach to bioengineering large quantity...
9.
Wang W, Ho P, Chen Q, Addepalli B, Limbach P, Li M, et al.
J Pharmacol Exp Ther
. 2015 May;
354(2):131-41.
PMID: 26022002
Development of anticancer treatments based on microRNA (miRNA/miR) such as miR-34a replacement therapy is limited to the use of synthetic RNAs with artificial modifications. Herein, we present a new approach...
10.
Li M, Addepalli B, Tu M, Chen Q, Wang W, Limbach P, et al.
Drug Metab Dispos
. 2015 May;
43(7):1129-36.
PMID: 25934574
In contrast to the growing interests in studying noncoding RNAs (ncRNAs) such as microRNA (miRNA or miR) pharmacoepigenetics, there is a lack of efficient means to cost effectively produce large...